Economy & Politics

B Medical’s success story continues in India

The manufacturer of ultra-low temperature refrigeration systems, based in Hosingen, will open its first factory abroad. Direction India, where work on the new production line will begin in February 2021.

Patrick JACQUEMOT

Patrick JACQUEMOT

The manufacturer of ultra-low temperature refrigeration systems, based in Hosingen, will open its first factory abroad. Direction India, where work on the new production line will begin in February 2021.

The covid crisis shed light on the expertise of B Medical Systems. In recent months, the specialist in cold chains for vaccines and medical refrigeration has seen its order book boosted like never before. But in recent weeks, to find its leaders, it was towards India that we had to look. Because it is on the side of New Delhi that things rushed for the company led by Luc Provost.


online.fr: Kühlaggregat-Hersteller B Medical Systems.Baut Kühlaggregate für Covid-Impfstoffe. Photo: Gerry Huberty / Luxemburger Wort

The company, based in northern Luxembourg, has seen its order book swell visibly in recent weeks. It is true that states are snapping up their fridges capable of keeping anti-covid doses at very low temperatures before vaccination.


“More precisely since the bilateral summit (by videoconference) between India and Luxembourg on November 19,” says the firm. That day, the two Prime Ministers, Xavier Bettel and Narendra Modi, evoke the covid crisis. It was then that the head of Luxembourg government placed the name of B Medical Systems, praising its abilities to help India carry out its vaccination campaign.

Since then contacts have been forged, official meetings have multiplied and representatives of the European site have flown to the country of 1.3 billion inhabitants to meet the highest national and regional authorities. And so an agreement has just been signed providing for the construction of a factory in the state of Gujarat, “in order to supply India with world-class products certified by the vaccine cold chain”.

“Our vision is to have at least 80% of the components manufactured and assembled in India to begin (in phase I) and move to 100% end-to-end manufacturing in India by phase II. All of these products will be made in India and none of the components will come from China, ”said Jesal Doshi, deputy general manager of B Medical Systems.

Eight transfers by plane, visit of nine cities, 75 meetings, 10 PCR tests carried out: the two weeks of visit to India were active for the leaders of B Medical Systems.

Eight transfers by plane, visit of nine cities, 75 meetings, 10 PCR tests carried out: the two weeks of visit to India were active for the leaders of B Medical Systems.

Photo: DR

Phase I expansion of 15 million euros, which will start in February 2021, will include the establishment of the plant. Site that will integrate around a hundred jobs first, with several hundred other short-term indirect job opportunities. This factory will manufacture products not only for the indian market, but will also serve the markets of Southeast Asia and East Africa.

Knowing that at present, B Medical is already distributed in more than 130 countries, and that some 400,000 of its products are currently in service on the planet.


Tags

Related Articles

Back to top button
Close
Close